絨毛性ゴナドトロピンの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイト＆予測

絨毛性ゴナドトロピンの市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4％で17億1,000万米ドルに成長します。予測期間の成長は、不妊症の有病率の増加、生殖医療に対する意識の高まり、生殖補助医療技術の採用の増加、高齢者の性腺機能低下症の有病率の増加、ヘルスケアインフラの拡大などに起因すると考えられます。予測期間における主要動向としては、技術の進歩、組換え技術の進歩、生殖補助医療技術の成長、研究開発への投資、ドラッグデリバリーシステムや製剤の革新などが挙げられます。

不妊症の有病率の増加は、絨毛性ゴナドトロピン（hCG）市場の成長を促進すると予想されます。不妊症とは、35歳以下の夫婦が避妊せずに定期的に性交を1年続けても妊娠しないこと、35歳以上の夫婦が避妊せずに性交を6ヶ月続けても妊娠しないことと定義されます。不妊症の増加は、多くの人が人生の後半に子どもを持つことを選択するため、出産が遅れること、また、肥満や喫煙などのライフスタイル要因が生殖機能に悪影響を与えることに起因しています。絨毛性ゴナドトロピンは、排卵を誘発し、黄体期をサポートし、男性のテストステロン産生を刺激するために不妊治療に使用されます。例えば、世界保健機関（WHO）は、2023年4月に、成人人口の17.5％、すなわち世界の6人に1人が不妊を経験していると報告し、不妊治療に対する需要の高まりを強調しています。したがって、不妊症の有病率の増加が絨毛性ゴナドトロピン市場の成長を牽引しています。

生殖補助医療（ART）の増加が絨毛性ゴナドトロピン市場の成長を促進すると予想されています。ARTには体外受精（IVF）のような医療処置が含まれ、個人やカップルの妊娠を助ける。ARTの増加の背景には、不妊率の上昇、医療の進歩、出産の遅れなどがあります。絨毛性ゴナドトロピンは、排卵を誘発し、胚移植後の黄体期をサポートすることで、ARTにおいて重要な役割を果たしています。MJHライフサイエンスによると、ARTの実施件数は大幅に増加し、卵子凍結の実施件数は2021年の2万4,560件から2022年には2万9,803件に増加しています。ARTが拡大し続けるにつれ、絨毛性ゴナドトロピンの需要も拡大すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界の絨毛性ゴナドトロピン：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の絨毛性ゴナドトロピン市場：成長率分析
• 世界の絨毛性ゴナドトロピン市場の実績：規模と成長、2019～2024年
• 世界の絨毛性ゴナドトロピン市場の予測：規模と成長、2024～2029年、2034年
• 世界の絨毛性ゴナドトロピン：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界の絨毛性ゴナドトロピン市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 人間用絨毛性ゴナドトロピン
• 動物用絨毛性ゴナドトロピン
• 世界の絨毛性ゴナドトロピン市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の絨毛性ゴナドトロピン市場：治療用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 男性性腺機能低下症
• 女性不妊治療
• 精子減少症治療
• 停留精巣治療
• 慢性疼痛
• その他
• 世界の絨毛性ゴナドトロピン市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究機関
• 製薬会社

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界の絨毛性ゴナドトロピン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の絨毛性ゴナドトロピン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• 絨毛性ゴナドトロピン市場：競合情勢
• 絨毛性ゴナドトロピン市場：企業プロファイル
  • Ferring Pharmaceuticals

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• 絨毛性ゴナドトロピン市場、2029年：新たな機会を提供する国
• 絨毛性ゴナドトロピン市場、2029年：新たな機会を提供するセグメント
• 絨毛性ゴナドトロピン市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Chorionic gonadotropin, specifically human chorionic gonadotropin (hCG), is a hormone produced by the placenta during pregnancy. It helps maintain progesterone levels by supporting the corpus luteum. hCG is used in medical treatments to induce ovulation in women, treat hypogonadism in men, and as a tumor marker for certain cancers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of chorionic gonadotropin are human chorionic gonadotropin and animal chorionic gonadotropin. Human chorionic gonadotropin (hCG) is primarily produced during pregnancy by cells in the placenta, which nourish the fertilized egg after it attaches to the uterine wall. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, for therapeutic applications such as male hypogonadism, female infertility treatment, oligospermic treatment, cryptorchidism treatment, chronic pain, and others. End users include research institutions and pharmaceutical companies.

The chorionic gonadotropin market research report is one of a series of new reports from The Business Research Company that provides chorionic gonadotropin market statistics, including chorionic gonadotropin industry global market size, regional shares, competitors with a chorionic gonadotropin market share, detailed chorionic gonadotropin market segments, market trends and opportunities, and any further data you may need to thrive in the chorionic gonadotropin industry. This chorionic gonadotropin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chorionic gonadotropin market size is expected to see steady growth in the next few years. It will grow to $1,710 million in 2029 at a compound annual growth rate (CAGR) of 4%. The growth in the forecast period can be attributed to increasing prevalence of infertility issues, rising awareness about reproductive health, increasing adoption of assisted reproductive technologies, rising prevalence of hypogonadism among the elderly, and expanding healthcare infrastructure. Major trends in the forecast period include technological advancements, advancements in recombinant technology, growth in assisted reproductive technology, investments in research and development, and innovations in drug delivery systems and formulations.

Increasing prevalence of infertility issues is expected to drive the growth of the chorionic gonadotropin (hCG) market. Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse for couples under 35, or after six months for those 35 and older. The rise in infertility is attributed to delayed childbearing, as many individuals choose to have children later in life, as well as lifestyle factors like obesity and smoking, which negatively impact reproductive health. Chorionic gonadotropin is used in fertility treatments to induce ovulation, support the luteal phase, and stimulate testosterone production in men. For example, the World Health Organization (WHO) reported in April 2023 that 17.5% of the adult population, or 1 in 6 people globally, experience infertility, highlighting the growing demand for fertility treatments. Therefore, the increasing prevalence of infertility issues is driving the growth of the chorionic gonadotropin market.

An increase in assisted reproductive technologies (ART) is expected to propel the growth of the chorionic gonadotropin market. ART includes medical procedures like in-vitro fertilization (IVF) that help individuals or couples achieve pregnancy. The rise in ART is driven by higher infertility rates, medical advancements, and delayed childbearing. Chorionic gonadotropin plays a crucial role in ART by triggering ovulation and supporting the luteal phase after embryo transfer. According to MJH Life Sciences, the number of ART cycles performed increased significantly, with egg freezing cycles rising from 24,560 in 2021 to 29,803 in 2022. As ART continues to expand, the demand for chorionic gonadotropin is also expected to grow.

A key trend in the chorionic gonadotropin market is the development of innovative solutions, such as saliva-based pregnancy tests, to improve convenience, accuracy, and accessibility. Saliva-based pregnancy tests detect the presence of hCG in saliva, offering a non-invasive and more comfortable alternative to traditional urine-based tests. In June 2023, Salignostics, an Israel-based biotech company, launched the world's first saliva-based pregnancy test, Salistick. This product enables women to determine pregnancy using a saliva sample, with results available in 5 to 15 minutes, providing a more convenient and discreet testing experience.

Key player operating in the chorionic gonadotropin market is Ferring Pharmaceuticalss.

North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chorionic gonadotropin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chorionic gonadotropin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chorionic gonadotropin market consists of sales of products including follicle-stimulating hormone, luteinizing hormone, menotropins, gonadotropin-releasing hormone, and clomiphene citrate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chorionic Gonadotropin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chorionic gonadotropin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chorionic gonadotropin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chorionic gonadotropin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
• 4) By End User: Research Institutions; Pharmaceutical Companies
• Companies Mentioned: Ferring Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chorionic Gonadotropin Market Characteristics

3. Chorionic Gonadotropin Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Chorionic Gonadotropin Market Trends And Strategies

5. Chorionic Gonadotropin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Chorionic Gonadotropin Growth Analysis And Strategic Analysis Framework

• 6.1. Global Chorionic Gonadotropin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Chorionic Gonadotropin Market Growth Rate Analysis
• 6.4. Global Chorionic Gonadotropin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Chorionic Gonadotropin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Chorionic Gonadotropin Total Addressable Market (TAM)

7. Global Chorionic Gonadotropin Market Pricing Analysis & Forecasts

8. Chorionic Gonadotropin Market Segmentation

• 8.1. Global Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Chorionic Gonadotropin
• Animal Chorionic Gonadotropin
• 8.2. Global Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 8.3. Global Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male Hypogonadism
• Female Infertility Treatment
• Oligospermic Treatment
• Cryptorchidism Treatment
• Chronic Pain
• Other Therapeutic Applications
• 8.4. Global Chorionic Gonadotropin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Institutions
• Pharmaceutical Companies

9. Global Chorionic Gonadotropin Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Chorionic Gonadotropin Market Regional And Country Analysis

• 10.1. Global Chorionic Gonadotropin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Chorionic Gonadotropin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Chorionic Gonadotropin Market

• 11.1. Asia-Pacific Chorionic Gonadotropin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Chorionic Gonadotropin Market

• 12.1. China Chorionic Gonadotropin Market Overview
• 12.2. China Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Chorionic Gonadotropin Market

• 13.1. India Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Chorionic Gonadotropin Market

• 14.1. Japan Chorionic Gonadotropin Market Overview
• 14.2. Japan Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Chorionic Gonadotropin Market

• 15.1. Australia Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Chorionic Gonadotropin Market

• 16.1. South Korea Chorionic Gonadotropin Market Overview
• 16.2. South Korea Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Chorionic Gonadotropin Market

• 17.1. Western Europe Chorionic Gonadotropin Market Overview
• 17.2. Western Europe Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Chorionic Gonadotropin Market

• 18.1. UK Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Chorionic Gonadotropin Market

• 19.1. Germany Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Chorionic Gonadotropin Market

• 20.1. France Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chorionic Gonadotropin Market

• 21.1. Eastern Europe Chorionic Gonadotropin Market Overview
• 21.2. Eastern Europe Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Chorionic Gonadotropin Market

• 22.1. North America Chorionic Gonadotropin Market Overview
• 22.2. North America Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Chorionic Gonadotropin Market

• 23.1. USA Chorionic Gonadotropin Market Overview
• 23.2. USA Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Chorionic Gonadotropin Market

• 24.1. Canada Chorionic Gonadotropin Market Overview
• 24.2. Canada Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Chorionic Gonadotropin Market

• 25.1. South America Chorionic Gonadotropin Market Overview
• 25.2. South America Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Chorionic Gonadotropin Market

• 26.1. Middle East Chorionic Gonadotropin Market Overview
• 26.2. Middle East Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Chorionic Gonadotropin Market

• 27.1. Africa Chorionic Gonadotropin Market Overview
• 27.2. Africa Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Chorionic Gonadotropin Market Competitive Landscape And Company Profiles

• 28.1. Chorionic Gonadotropin Market Competitive Landscape
• 28.2. Chorionic Gonadotropin Market Company Profiles
  • 28.2.1. Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

29. Global Chorionic Gonadotropin Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Chorionic Gonadotropin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Chorionic Gonadotropin Market

32. Recent Developments In The Chorionic Gonadotropin Market

33. Chorionic Gonadotropin Market High Potential Countries, Segments and Strategies

• 33.1 Chorionic Gonadotropin Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Chorionic Gonadotropin Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Chorionic Gonadotropin Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer